Skip to main content

Advertisement

SpringerLink
Log in

Constitutional pericentric inversion of chromosome 9 has no impact on survival in chronic myelogenous leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1

References

  1. Lee SG, Park TS, Lim G, Lee KA, Song J, Choi JR (2010) Constitutional pericentric inversion 9 and hematological disorders: a Korean tertiary institution’s experience over eight years. Ann Clin Lab Sci 40(3):273–277

    PubMed  Google Scholar 

  2. Wan TS, Ma SK, Chan LC (2000) Acquired pericentric inversion of chromosome 9 in essential thrombocythemia. Hum Genet 106(6):669–670

    Article  CAS  PubMed  Google Scholar 

  3. Imashuku S, Naya M, An B, Nakabayashi Y, Kuriyama K, Udeda I, Morimoto A, Hibi S, Todo S (2002) Constitutional pericentric inversion of chromosome 9 and haemopoietic stem cell transplantation: delayed engraftment. Br J Haematol 118(4):1195–1196

    Article  PubMed  Google Scholar 

  4. Keung YK, Knovich MA, Powell BL, Buss DH, Pettenati M (2003) Constitutional pericentric inversion of chromosome 9 and acute leukemia. Cancer Genet Cytogenet 145(1):82–85

    Article  CAS  PubMed  Google Scholar 

  5. Vaniawala S, Pankaj G (2014) Constitutional pericentric inversion of chromosome 9 and chronic myeloid leukemia. A J Clin Exp Med 2(6):128–131

    Article  Google Scholar 

  6. Suh B, Song J, Kim J, Park TS, Choi JR (2010) Constitutional pericentric inversion 9 in Korean patients with chronic myelogenous leukemia. Korean J Lab Med 30(3):218–223. doi:10.3343/kjlm.2010.30.3.218

    Article  CAS  PubMed  Google Scholar 

  7. Wang W, Cortes JE, Lin P, Beaty MW, Ai D, Amin HM, McDonnell TJ, Ok CY, Kantarjian HM, Medeiros LJ, Hu S (2015) Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Blood 126(14):1699–1706. doi:10.1182/blood-2015-05-646489

    Article  CAS  PubMed  Google Scholar 

  8. Wang W, Cortes JE, Lin P, Khoury JD, Ai D, Tang Z, Tang G, Jorgensen JL, Medeiros LJ, Hu S (2015) Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia 29(11):2263–2266. doi:10.1038/leu.2015.96

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

    Wei Wang, Sehreen Ali, Zhenya Tang, Roberto N. Miranda, Su Yang, L. Jeffrey Medeiros & Shimin Hu

Authors
  1. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sehreen Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhenya Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roberto N. Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Su Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Jeffrey Medeiros
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shimin Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shimin Hu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Ali, S., Tang, Z. et al. Constitutional pericentric inversion of chromosome 9 has no impact on survival in chronic myelogenous leukemia. Ann Hematol 95, 657–659 (2016). https://doi.org/10.1007/s00277-016-2592-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2592-3

Keywords

Search

Navigation